Patient Author, The Yellow Cape, Newark, DE, USA.
Center for Endometriosis Research and Treatment, UC San Diego, La Jolla, CA, USA.
Adv Ther. 2024 Dec;41(12):4369-4376. doi: 10.1007/s12325-024-02970-2. Epub 2024 Oct 19.
Endometriosis is a common disease, affecting approximately 5-10% of reproductively aged women. Symptoms, such as painful periods, negatively impact an individual's quality of life; however, these symptoms are often normalized, leading to delays in diagnosis and treatment, and worsening of the disease. In this podcast, a reproductive endocrinologist (Dr Sanjay K Agarwal) and patient advocate (Tara Mangum) provide their perspectives on the diagnosis and management of endometriosis. They also discuss Relugolix combination therapy as a treatment option for patients with endometriosis.Podcast available for this article.
子宫内膜异位症是一种常见疾病，影响大约 5-10%的育龄妇女。疼痛等症状会对个人的生活质量产生负面影响；然而，这些症状常常被视为正常，导致诊断和治疗的延误，以及疾病的恶化。在本期播客中，一位生殖内分泌学家（Sanjay K Agarwal 博士）和患者倡导者（Tara Mangum）就子宫内膜异位症的诊断和管理提供了他们的观点。他们还讨论了 Relugolix 联合疗法作为子宫内膜异位症患者的一种治疗选择。本文提供播客。
